| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.8B | $1.2B | $3.9B | $3.2B | $0.8B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B |
| Net Income | $0.3B | $0.7B | $0.1B | $0.1B | $0.4B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $67.11 | $164.62 | $11.76 | $13.83 | $70.65 | $47.45 | $27.45 | $10.69 |
| EPS (Diluted) | $66.47 | $163.40 | $11.72 | $13.79 | $70.45 | $47.34 | $27.25 | $10.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $7.7B | $7.2B | $6.6B | $7.4B | $6.4B | $5.9B | $4.8B |
| Current Assets | $2.4B | $2.1B | $1.8B | $1.7B | $1.8B | $1.8B | $1.7B | $1.5B |
| Cash & Equivalents | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.4B | $0.2B | $0.3B |
| Total Liabilities | $3.5B | $3.3B | $3.2B | $2.8B | $3.0B | $2.7B | $2.6B | $1.8B |
| Current Liabilities | $1.4B | $1.2B | $1.2B | $1.2B | $1.2B | $0.9B | $1.0B | $0.8B |
| Stockholders' Equity | $4.8B | $4.3B | $4.0B | $3.7B | $4.4B | $3.8B | $3.3B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.2B | $-0.2B | $-0.5B | $0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.1B | $-0.0B | $0.0B | $-0.2B | $0.0B | $-0.2B |